First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial.
about
Chemotherapy for advanced non-small cell lung cancer in the elderly populationHas aidi injection the attenuation and synergistic efficacy to gemcitabine and cisplatin in non-small cell lung cancer? A meta-analysis of 36 randomized controlled trials.Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphismHealth-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials.Reliability and validity of a Dutch version of the Leicester Cough Questionnaire.Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based AnalysisThe effect of chemotherapy on symptom control and quality of life in patients with advanced non-small cell lung cancer.Use of the lung cancer-specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials: A systematic review of the literature 20 years after its development.Amrubicin, a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo.Societal savings in patients with advanced non-squamous non-small-cell lung cancer receiving bevacizumab-based versus non-bevacizumab-based treatments in France, Germany, Italy, and Spain.Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and Paclitaxel as first-line treatment.In Vivo SELEX of an Inhibitory NSCLC-Specific RNA Aptamer from PEGylated RNA Library.
P2860
Q24186466-2D14F8F4-506B-460F-86CD-F11E1CB442BBQ33437216-1547F033-D224-42B8-B8CD-52DEB76A022CQ33847161-C5729D18-3BE9-4012-8D1A-B8BAF583A69CQ35111780-4727DA40-55D3-4884-86EB-90718E5E1466Q35649145-0E0056C5-7E2D-4D1E-990F-191924BC1B0CQ36040002-1ABF3139-9360-4D44-9188-883907E517BCQ36448679-B6960DE9-155D-4674-9098-C6DEA783AE0BQ38602994-E210F7B8-A623-4AF9-BAF7-87649795705EQ40184647-5D4AFD3D-F3EA-48E4-AEF9-4CB56DDC3F55Q41899597-A6D3D6AA-9F3D-4AE5-8883-D1F0B88D0EB4Q46601887-98278292-0090-404C-AC74-27CC317478ABQ49196378-5E907F60-CC92-45C9-A931-4A2560716C12
P2860
First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
First-line gemcitabine with ci ...... ung cancer: a phase III trial.
@ast
First-line gemcitabine with ci ...... ung cancer: a phase III trial.
@en
type
label
First-line gemcitabine with ci ...... ung cancer: a phase III trial.
@ast
First-line gemcitabine with ci ...... ung cancer: a phase III trial.
@en
prefLabel
First-line gemcitabine with ci ...... ung cancer: a phase III trial.
@ast
First-line gemcitabine with ci ...... ung cancer: a phase III trial.
@en
P2093
P2860
P356
P1476
First-line gemcitabine with ci ...... ung cancer: a phase III trial.
@en
P2093
E G E de Vries
F M Wachters
G P J de Leede
H J M Groen
H M Boezen
J H Strijbos
J W G Van Putten
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601283
P407
P577
2003-10-01T00:00:00Z
P5875
P6179
1042150237